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Introduction:
• Adverse drug events refer to an individual being 
harmed due to taking a medication. These risks can 
include side effects, damage to different organs, senses 
impairment and more. 
• The older adult population has the highest risk for 
adverse drug events. Antibiotics and anticoagulants are 
some examples of medication that cause higher 
adverse events in the elderly. The risks can increase as 
more medications are included.
\
Introduction:
Purpose:
Methodology:
I Chi-Square 
Test
Yes No Marginal Row 
Totals
Medications 
>=5
54 
(47.5)[0.89]
15 
(21.5)[1.97]
69
Medications 
>=7
41 
(47.5)[0.89]
28 
(21.5)[1.97]
69
Marginal 
Column Totals
95 43 138
• Polypharmacy numbers >=5 and >=7 were 
compared to identify the significance of the 
definitions. 
• Chi-square statistics shows a significance with a 
p-value of 0.02. 
• 79% were polypharmacy >=5 and 59% with >=7.  
• Over half of the participants are considered in 
the polypharmacy.
• Pie-charts indicate percentages of medical 
conditions that each group consists of to help 
further understand study implications.
These events are preventable with caution, but it is 
important to recognize which medications are taken 
and the possible interactions/risks for the elderly. The 
purpose of this study was to evaluate the number of 
high-risk medications used by older adults (age 60 
and older) living In a low-income community-based 
housing. 
• Participants included had no history of dementia, 
Alzheimer’s, or Lewy-body disease.
• Data was collected at senior apartment buildings 
in the Richmond area and at the VCU Health 
Clinic through the Richmond Health and Wellness 
Program (RHWP) among Older Adults.
• Variables considered in the model include; 1) 
Social Determinants of Health (SDH) as defined 
by income, race/ethnicity, and education; 2) 
Medication risk was measured by polypharmacy 
definitions >=5 and >=7 medications. 
Results:
Discussion:
• The results allow for us to see that even with a 
smaller sample, the cut-off number for 
polypharmacy can be essential. 
• Further studies could include identifying and 
comparing demographics for polypharmacy. 
• Adverse drug events and drug-drug interaction 
risks can also increase with these implications.
